N/A Completed N=56 Randomized Quadruple-blind Treatment

Vitamin D Supplementation in Healthy Adolescents

Vitamin D Supplementation

Source: ClinicalTrials.gov NCT01126671 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2013

Primary outcomePrimary: Baseline 25 Hydroxy Vitamin D (25OHD) Levels — 28.1; 29 ng/ml

Summary

This double blind, randomized controlled trial compares two supplemental doses of vitamin D in health adolescents.

Outcome Measures

Outcome	Result	p-value
PRIMARY Baseline 25 Hydroxy Vitamin D (25OHD) Levels	28.1; 29	—
PRIMARY Follow-up 25OHD Levels	28.9; 30.1	—
SECONDARY Baseline Assessment of Bone Markers	1.4; 1.74	—
SECONDARY Assessment of Bone Markers at Follow-up	31.1; 32.3	—

Eligibility Criteria

Inclusion Criteria

11-18 years old
healthy

Exclusion Criteria

chronic disease
use of medication known to effect bone or vitamin D metabolism
abnormal vitamin D or calcium at screening
pregnant
body mass index 95%

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01126671). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.